Roche to show investors strength in and beyond cancer drugs

ZURICH (Reuters) - Swiss drugmaker Roche will highlight its most promising treatments in oncology, immunology and ophthalmology at an investor event on Tuesday, as it seeks to show its potential in and beyond its core cancer expertise. The world's biggest maker of cancer medicines cited etrolizumab in inflammatory bowel disease and lampalizumab, a treatment for the dry form of age-related macular degeneration (AMD), as among its most promising therapies. The Basel-based firm is also developing so-called "follow on" drugs that it hopes will replace or breathe new life into old cancer products. ...



via Health News Headlines - Yahoo! News http://news.yahoo.com/roche-show-investors-strength-beyond-cancer-drugs-061753681--finance.html